Anti-CD38 Pretargeted Radioimmunotherapy Demonstrates Therapeutic Efficacy In a Human Multiple Myeloma Mouse Xenograft Model

• Published in: Blood Vol. 118; no. 21; p. 1842
• Main Authors: Green, Damian J., Orgun, Nural N., Hylarides, Mark D., Pagel, John M., Hamlin, Donald K., Wilbur, D. Scott, Lin, Yukang, Kenoyer, Amiee L., Frayo, Shani L., Bensinger, William I., Gopal, Ajay K., Orozco, Johnnie J., Gooley, Theodore A., Wood, Brent L., Press, Oliver W.
• Format: Journal Article
• Language: English
• Published: Elsevier Inc 18.11.2011

Abstract 1842 Multiple myeloma (MM) remains incurable despite improved response rates and improved progression free survival in the era of therapy with novel agents, including bortezomib, thalidomide, and lenalidomide. Disease persistence is presumably due to residual malignant plasma cell clones th...